Mergers & Acquisitions

Filter

Current filters:

None

Popular Filters

790 to 814 of 917 results

Lundbeck buys remaining rights to desmoteplase from Paion

29-02-2012

Danish CNS drug specialist Lundbeck A/S (LUND: DC) and Germany’s Paion AG (FSE: PA8) have entered…

Cardio-vasculardesmoteplaseLundbeckMergers & AcquisitionsPaionPharmaceutical

Roche extends Illumina takeover deadline

28-02-2012

Roche has extended its $5.7 billion hostile takeover offer for genetic sequencing specialist Illumina…

HomeIlluminaMergers & AcquisitionsPharmaceuticalRoche

Herborium signs Lol to be acquired by China Health Resource

26-02-2012

New Jersey, USA-based botanical therapeutics company Herborium (Pink Sheets: HBRM) says it has signed…

China Health ResourceHerboriumMergers & AcquisitionsPharmaceutical

Flaws in ESI/Medco efficiency claims exposed

20-02-2012

David Balto, an antitrust attorney in Washington DC, USA, and former Policy Director of the Federal Trade…

Express ScriptsLegalMedcoMergers & AcquisitionsPharmaceutical

uniQure to acquire Amsterdam Molecular Therapeutics business

19-02-2012

Netherlands-based human gene based therapies developer Amsterdam Molecular Therapeutics (Euronext: AMT)…

Amsterdam MolecularBiotechnologyMergers & AcquisitionsuniQure

Pfizer and Hisun flesh-out plans for generics JV in China

19-02-2012

Global drugs behemoth Pfizer (NYSE: PFE) and Zhejiang Hisun Pharmaceutical (SSE Code: 600267), a leading…

Asia-PacificGenericsMergers & AcquisitionsPfizerZhejiang Hisun Pharma

Merck & Co sets up marketing JV in Brazil

16-02-2012

Merck & Co (NYSE: MRK) says it has formed a new joint venture with Supera Farma Laboratorios, a Brazilian…

CristaliaEurofarmaGenericsMarkets & MarketingMerck & CoMergers & AcquisitionsPharmaceuticalSouth AmericaSupera Farma

Karo Bio drops eprotirome and split up plans

15-02-2012

There was a double-dose of bad news for Sweden’s Karo Bio (STO: KARO), which this week said it would…

BiotechnologyCardio-vasculareprotiromeKaro BioMergers & AcquisitionsPharmaceuticalRegulation

Maruho boosts US presence with Cutanea acquisition

15-02-2012

Japan’s Maruho says it has acquired Cutanea Life Sciences (CLS), a privately held dermatology development…

Cutanea Life SciencesDermatologicalsMaruhoMergers & AcquisitionsPharmaceutical

Riemser strengthens oncology range with Roche drug

15-02-2012

German drugmaker Riemser Arzneimittel AG is extending its range of supportive cancer therapy products…

Mergers & AcquisitionsOncologyOstacPharmaceuticalRiemser ArztneimittelRoche

Biogen Idec in deal to buy Stromedix

15-02-2012

S biotech firm Biogen Idec (Nasdaq: BIIB) has entered into a definitive agreement to acquire Stromedix,…

Biogen IdecBiotechnologyMergers & AcquisitionsStromedix

Valeant bags another company, Eyetech

14-02-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says that it has agreed…

BiotechnologyEyetechMacugenMergers & AcquisitionsOphthalmicsPharmaceuticalValeant Pharmaceuticals

Cytomedix expands in regenerative medicines, buying Aldagen

10-02-2012

USA-based regenerative wound care specialist Cytomedix (OTC.BB: CMXI.OB) said yesterday that it has…

AldagenCytomedixMergers & AcquisitionsPharmaceutical

Illumina board says Roche hostile bid “grossly inadequate”

08-02-2012

Having thoroughly reviewed Swiss drug and diagnostics major Roche’s (ROG: SIX) hostile takeover…

IlluminaMergers & AcquisitionsPharmaceuticalRoche

Shanghai Pharma aims to take control of Kony Pharma

07-02-2012

In a regulatory filing with the Hong Kong Stock Exchange yesterday, Shanghai Pharmaceuticals Holding…

Asia-PacificGenericsKony PharmaMergers & AcquisitionsShanghai Pharmaceutical Group

Biotech deal-making off to a strong start in 2012, says Burrill

02-02-2012

Swiss drug major Roche's hostile $5.7 billion bid for the tools and sequencing systems company Illumina…

BiotechnologyFinancialLicensingMergers & AcquisitionsNorth America

New Actavis/Bioton alliance aims to shake up diabetes market

31-01-2012

Icelandic generics drugmaker Actavis and Poland’s Bioton (WSE: BIO) have formed a joint venture…

ActavisBiotonDiabetesGenericsMarkets & MarketingMergers & AcquisitionsPharmaceutical

STADA and Grunenthal agree lower price for certain branded products

30-01-2012

German drugmakers STADA Arzneimittel (SAZ: GR) and family-owned Grunenthal have agreed on the purchase…

EuropeGenericsGrunenthalMergers & AcquisitionsSTADA Arzneimittel

Amgen to acquire US/German biotech firm

27-01-2012

Adding to the strong start this year for M&A activity in the Pharma/Biotech sector, USA-based Amgen (Nasdaq:…

AmgenBiotechnologyMergers & AcquisitionsMicrometOncology

Celgene to buy Avila; posts strong 4th-qtr results

27-01-2012

USA-based Celgene (Nasdaq: CELG) yesterday revealed that it has entered into a definitive merger deal…

Avila TherapeuticsBiotechnologyCelgeneFinancialMergers & AcquisitionsOncologyPharmaceutical

Illumina implements “poison pill” with regard to Roche bid

27-01-2012

Responding to Swiss drug major Roche’s (ROG: SIX) hostile takeover over offer of $44.50 per share…

IlluminaMergers & AcquisitionsPharmaceuticalRoche

Spectrum Pharma to acquire non-US rights to market Zevalin

26-01-2012

USA-based Spectrum Pharmaceuticals (NasdaqGS: SPPI) says it has entered into an agreement to acquire…

BayerMergers & AcquisitionsOncologyPharmaceuticalSpectrum PharmaceuticalsZevalin

790 to 814 of 917 results

Back to top